No adverse effects to influenza antiviral medications in pregnancy: Maternal and neonatal outcomes after antepartum treatment of influenza antiviral m

Via CIDRAP News:

Researchers from the University of Texas Southwest Medical Center report that neither oseltamivir nor amantadine/rimantadine caused any adverse events in pregnant women treated at the medical center during the H1N1 influenza pandemic. The 104 women given amantadine or rimantadine and the 135 women given oseltamivir had the same rates of preterm birth, premature rupture of membranes, gestational diabetes, and preeclampsia as the 82,097 women who did not receive antivirals.

http://journals.lww.com/greenjournal/Abstract/2010/04000/Maternal_and_Neonatal_Outcomes_After_Antepartum.7.aspx?rss